普通外文研报
Dassault Systèmes Growth profile showing signs of relative consistency
研报英文原文证据摘录
Dassault Systèmes Growth profile showing signs of relative consistency
J P M O R G A N Europe Equity Research
24 July 2026
Dassault Systèmes Neutral
DAST.PA, DSY FP
Growth profile showing signs of relative consistency Price (23 Jul 26):€18.42
▲Price Target (Dec-27):€22.00
Prior (Dec-27):€21.00
With Dassault Systemes Q2 revenue growth of 4% Y/Y CC (first take), the current
trend is slight outperformance relative to expectations in terms of growth. The Q3 European Tech Software & IT
Servicesgrowth guidance of 3-5% Y/Y CC implies broadly stable revenue growth relative
to Q2’s 4%. Assuming the midpoint of the Q3 growth guidance, the FY26 growth Toby Ogg AC
guidance of 3-5% Y/Y CC only requires a modest acceleration in Q4 growth (44-20) 7742-3278
toby.ogg@jpmorgan.com
relative to Q3 at the midpoint. Hence, it looks as though the current FY26 guidance J.P. Morgan Securities plc
is achievable and the low end of 3% looks increasingly de-risked. Within the
Joseph George
revenue mix, Industrial Innovation recovered to 5% Y/Y CC, Life Sciences (44-20) 3493-6990
worsened slightly with -4% Y/Y CC and Mainstream Innovation delivered 8% Y/Y joe.george@jpmorgan.com
CC. Thus from a revenue mix perspective, the only slight negative was the Life J.P. Morgan Securities plc
Sciences weakening, though the largely diminished Moderna drag should help Priya R Suneja
somewhat in H2. Looking forward, the growth profile has become relatively more (91-22) 6157 4721
consistent over the past few quarters, which is a positive. The Q3 growth guidance priya.suneja@jpmchase.com
implies stable growth, which doesn’t look too demanding, and the FY26 guidance J.P. Morgan India Private Limited
looks increasingly achievable. The ArisGlobal deal is likely to remain a debate Giulio Gambardella
本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。
打开研报阅读器